Inogen | INGN - Ordinary Share Capital


Inogen reported $23K in Ordinary Share Capital for its fiscal quarter ending in December of 2023.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 50.64M 7K Jun/2026
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 377.4M 8.5M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Globus Medical USD 135.67M 611K Mar/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.35M 87K Jun/2026
Medtronic USD 1.28B 1.38M Dec/2025
Orthofix International USD 39.83M 315K Dec/2025
Philips EUR 952.02M 729K Mar/2026
ResMed USD 145.06M 45.78M Jun/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 69.54M 1.04M Jun/2026
Teleflex USD 44.26M 70K Mar/2026
X T L Biopharmaceuticals USD 946.24M 64.86M Dec/2025
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026